10.1016/j.bbamem.2006.02.015
10.1016/j.taap.2012.08.005
10.1016/j.molcel.2007.03.016
10.1016/s0027-5107(01)00091-4
10.1016/0003-9861(84)90010-9
10.1158/0008-5472.can-07-5259
10.1007/s00018-009-0099-y
10.1023/b:cbto.0000004952.07979.3d
10.1016/j.ccr.2011.08.024
10.1016/j.semcancer.2013.08.007
10.1016/j.ccr.2007.08.004
10.1016/j.cmet.2005.05.001
10.1161/01.ATV.0000258979.92828.bc
10.3109/10715761003667554
10.1016/j.exger.2010.01.003
10.1016/j.bbamcr.2006.09.006
10.1097/00062752-199502010-00008
Cui S., 1994, Activated murine macrophages induce apoptosis in tumor cells through nitric oxide-dependent or -independent mechanisms, Cancer Research, 54, 2462
10.1080/09553009414550041
10.1007/s13277-013-0804-1
10.1016/j.cbi.2005.12.009
10.1080/10408360500523878
10.1016/0959-8049(96)00051-2
10.1016/s0009-2797(98)00008-8
10.1016/j.bbcan.2010.07.004
10.1016/j.ccell.2014.11.019
10.1046/j.1432-1327.2000.01701.x
10.1126/science.275.5296.90
10.1093/embo-reports/kve046
10.1016/s0891-5849(00)00313-0
Kawahara N., 1996, Enhanced coexpression of thioredoxin and high mobility group protein 1 genes in human hepatocellular carcinoma and the possible association with decreased sensitivity to cisplatin, Cancer Research, 56, 5330
Yokomizo A., 1995, Cellular levels of thioredoxin associated with drug sensitivity to cisplatin, mitomycin C, doxorubicin, and etoposide, Cancer Research, 55, 4293
10.1016/j.mad.2004.08.012
Ho J. C.-M., 2001, Differential expression of manganese superoxide dismutase and catalase in lung cancer, Cancer Research, 61, 8578
10.1097/00029330-200712010-00006
Janssen A. M. L., 2000, Superoxide dismutases in gastric and esophageal cancer and the prognostic impact in gastric cancer, Clinical Cancer Research, 6, 3183
Salzman R., 2007, Increased activity of superoxide dismutase in advanced stages of head and neck squamous cell carcinoma with locoregional metastases, Neoplasma, 54, 321
10.1016/j.freeradbiomed.2015.04.001
Nelson K. K., 2003, Elevated Sod2 activity augments matrix metalloproteinase expression: evidence for the involvement of endogenous hydrogen peroxide in regulating metastasis, Clinical Cancer Research, 9, 424
10.1016/j.febslet.2007.08.021
Cullen J. J., 2003, The role of manganese superoxide dismutase in the growth of pancreatic adenocarcinoma, Cancer Research, 63, 1297
Oberley L. W., 1979, Role of superoxide dismutase in cancer: a review, Cancer Research, 39, 1141
10.1128/MCB.25.17.7758-7769.2005
10.1016/j.biopha.2005.03.006
10.1089/152308604773934260
10.1002/(sici)1097-0045(19980515)35:3lt;221::aid-pros8>3.0.co;2-j
10.1016/0005-2744(70)90052-5
10.1016/j.jinorgbio.2009.07.011
10.1016/s0891-5849(00)00512-8
10.1016/s0891-5849(98)00092-6
10.1111/j.1432-1033.1995.tb20798.x
10.1007/s13277-014-2714-2
10.1158/1078-0432.ccr-06-2082
10.1097/00008390-199810000-00001
Bechtel W., 2009, Modulation of intercellular ROS signaling of human tumor cells, Anticancer Research, 29, 4559
Bechtel W., 2009, Catalase protects tumor cells from apoptosis induction by intercellular ROS signaling, Anticancer Research, 29, 4541
Bauer G., 2000, Reactive oxygen and nitrogen species: efficient, selective, and interactive signals during intercellular induction of apoptosis, Anticancer Research, 20, 4115
Bauer G., 2012, Tumor cell-protective catalase as a novel target for rational therapeutic approaches based on specific intercellular ROS signaling, Anticancer Research, 32, 2599
10.1016/j.fob.2012.12.002
10.1111/j.1440-1843.2006.00849.x
10.1016/j.bbapap.2014.11.011
10.1016/j.mam.2007.04.005
Wei S. J., 2000, Thioredoxin nuclear translocation and interaction with redox factor-1 activates the activator protein-1 transcription factor in response to ionizing radiation, Cancer Research, 60, 6688
Bobola M. S., 2001, Apurinic/apyrimidinic endonuclease activity is elevated in human adult gliomas, Clinical Cancer Research, 7, 3510
10.1111/j.1751-2980.2010.00442.x
10.1016/j.canlet.2004.11.007
10.1016/j.freeradbiomed.2013.06.041
10.2174/09298673113209990154
10.1016/j.redox.2012.10.001
10.1016/j.tibs.2008.12.008
10.1158/0008-5472.can-05-1997
10.1016/j.freeradbiomed.2011.09.035
10.1016/j.cell.2011.07.032
10.1016/j.canlet.2008.03.035
10.1517/14728222.2013.772136
10.1016/j.freeradbiomed.2011.05.018
10.1126/scitranslmed.3007653
10.1126/scitranslmed.3008488
10.1126/scitranslmed.3007154
10.1007/s12094-013-1028-y
10.1182/blood-2011-06-334672
10.1371/journal.pone.0050591
10.1016/j.bbrc.2004.03.110
10.1016/j.neures.2010.04.002
10.1371/journal.pbio.0020362
10.1016/j.freeradbiomed.2014.03.026
10.1016/j.phytochem.2014.09.001
10.1146/annurev.pharmtox.44.101802.121851
10.1016/j.bbagen.2014.10.008
10.1016/j.tiv.2011.05.006
10.1016/j.ejmech.2013.12.015
10.1016/j.febslet.2010.05.054
10.1016/j.lfs.2013.12.009
10.1007/s12079-007-0006-y
10.1158/0008-5472.can-06-3914
10.1016/j.toxlet.2012.02.020
10.1371/journal.pone.0070956
10.1016/j.bbabio.2015.02.012
10.1016/j.freeradbiomed.2007.03.020
10.7164/antibiotics.33.426
10.3109/10715762.2013.819974
10.1007/s10495-007-0082-8
10.1016/j.bbrc.2006.06.140
10.1096/fasebj.4.13.2210154
10.1016/j.yjmcc.2006.06.009
10.1016/j.bbabio.2012.09.016
10.1007/s00280-015-2739-2
10.1016/j.bbamcr.2007.05.002
10.1007/s11515-012-1204-4
10.1016/j.tiv.2013.11.006
